Abstract
Theoretically derived scaling laws capture the non-linear relationships between rapidly expanding brain volume and cortical gyrification across mammalian species and in adult humans. However, the preservation of these laws has not been comprehensively assessed in typical or pathological brain development. Here we assessed the scaling laws governing cortical thickness, surface area and cortical folding in the neonatal brain. We also assessed multivariate morphological terms that capture brain size, shape and folding processes. The sample consisted of 375 typically developing infants, 73 preterm infants and 107 infants with congenital heart disease (CHD) who underwent brain magnetic resonance imaging (MRI). Our results show that typically developing neonates and those with CHD follow the cortical folding scaling law obtained from mammalian brains, children and adults which captures the relationship between exposed surface area, total surface area and cortical thickness. Cortical folding scaling was not affected by gestational age at birth, postmenstrual age at scan, sex or multiple birth in these populations. CHD was characterized by a unique reduction in the multivariate morphological term capturing size, suggesting CHD affects cortical growth overall but not cortical folding processes. In contrast, preterm birth was characterized by altered cortical folding scaling and altered shape, suggesting the developmentally programmed processes of cortical folding are disrupted in this population. The degree of altered shape was associated with cognitive abilities in early childhood in preterm infants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Medical Research Council (MRC) UK [MR/L011530/1, MR/V002465/1], the British Heart Foundation [FS/15/55/31649] and Action Medical Research [GN2630]. The Developing Human Connectome Project was funded by the European Research Council under the European Union's Seventh Framework Program [FP7/20072013]/European Research Council grant agreement no. 319456. This research was supported by the Wellcome Engineering and Physical Sciences Research Council Centre for Medical Engineering at King's College London [WT 203148/Z/16/Z], and by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. JO is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society [206675/Z/17/Z]. TA receives funding from the MRC via a translation support award [MR/V036874/1] and a senior clinical fellowship [MR/Y009665/1]. ADE, JO, MAR and TA receive funding from the MRC Centre for Neurodevelopmental Disorders, King's College London [MR/N026063/1]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Research Ethics Service provided ethical approval (CHD: 07/H0707/105, 21/WA/0075; dHCP 14/LO/1169).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
